News & Insight
29 July 2021
News
IMAXT’s Nic Walton: uniting across disciplines to share learnings in data science
On the surface, astronomy has little overlap with bioinformatics, mutational analysis and other areas of cancer biology. But, as described by IMAXT’s Nic Walton, an astronomer based at the University of Cambridge, there’s much to learn…
Latest publication
OPTIMISTICC
09 June 2021
Latest tweet
Have you watched our latest interview with Professor Sir Mike Stratton @sangerinstitute? He discusses more on how o… https://t.co/CnodEWaGxf Mon Jul 26 10:00:33 +0000 2021
News and insight archive
News
On the surface, astronomy has little overlap with bioinformatics, mutational analysis and other areas of cancer biology. But, as described by IMAXT’s Nic Walton, an astronomer based at the University of Cambridge, there…
29 July 2021
Video
Sir Mike Stratton, based at the Wellcome Sanger Institute in Cambridge, UK, leads the Cancer Grand Challenges Mutographs team.
Mutographs unites genomicists with epidemiologists, building on recent developments in…
22 July 2021
News
Earlier this year, COSMIC - the world's largest and most comprehensive resource for exploring somatic mutations in cancer - celebrated the curation of its 10 millionth mutation.
PhD student Ellie Dunstone discusses…
13 July 2021
Video
Johanna Joyce is co-investigator of the Cancer Grand Challenges IMAXT team, based in Lausanne, Switzerland.
We caught up with Johanna to learn how diverse, global collaboration is helping to unlock new information…
30 June 2021
Video
Nearly 170 diverse, global teams submitted bold ideas outlining how they would solve some of cancer’s toughest challenges. Today, we reveal the 11 teams selected to compete for a share of £80m.
We were delighted to…
21 June 2021
News
APC is one of the most commonly mutated genes in colorectal tumours – but why is it so frequently mutated in this type of cancer compared to others?
The answer lies in the way Apc-mutant cells compete with their…
3 June 2021
Video
Patient advocate Helen Matthews meets co-investigator Owen Sansom to discuss SPECIFICANCER’s latest findings, how working cross-discipline enables ‘big strides forward’ and the unique, important perspectives brought to…
1 June 2021
News
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.
OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and…
21 April 2021
News
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand Challenges PRECISION team could spare thousands of women around the…
15 April 2021